Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Uveitis: what do we know and how does it help?

S Lightman1

  • 1Institute of Ophthalmology and Moorfields Eye Hospital, London, UK. s.lightman@ucl.ac.uk

Clinical & Experimental Ophthalmology
|May 9, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Feasibility of salivary cortisol collection in patients and companions attending dementia diagnostic meetings in memory clinics.

BMC research notes·2021
Same author

Growth hormone secretion, fatigue and quality of life after childhood traumatic brain injury.

European journal of endocrinology·2019
Same author

Pegylated interferon-α-2b reduces corticosteroid requirement in patients with Behçet's disease with upregulation of circulating regulatory T cells and reduction of Th17.

Annals of the rheumatic diseases·2014
Same author

Visual prognosis in Behçet's disease.

Ocular immunology and inflammation·2012
Same author

Systemic steroid prophylaxis for cataract surgery in patients with posterior uveitis.

Ocular immunology and inflammation·2012
Same author

Primary trabeculectomy with 5-fluorouracil for glaucoma secondary to uveitis.

Ocular immunology and inflammation·2012
Same journal

Biopsy of Iris and Anterior Chamber Tumours: Fine Needle, Minimally Invasive and Excision Techniques - Review.

Clinical & experimental ophthalmology·2026
Same journal

Ray-Tracing-Based Intraocular Lens Power Calculation in Combined Cataract Surgery and Descemet Membrane Endothelial Keratoplasty.

Clinical & experimental ophthalmology·2026
Same journal

Comparative Efficacy of Two Defocus Soft Contact Lenses on Axial Length and Choroid in High Myopic Adolescents: Comment.

Clinical & experimental ophthalmology·2026
Same journal

Lessons Learnt From 25 Years of Endophthalmitis: Causes, Microbiology and Visual Outcome Trends.

Clinical & experimental ophthalmology·2026
Same journal

Aqueous Humour Outflow Assessment Using Imaging-Based Techniques in Angle-Based Minimally Invasive Glaucoma Surgery (MIGS): A Systematic Review.

Clinical & experimental ophthalmology·2026
Same journal

Interpreting Hyperreflective Foci in Age-Related Macular Degeneration: A Critical Review of Cell Origins, Evolving Terminology and Clinical Utility.

Clinical & experimental ophthalmology·2026
See all related articles

New research reveals distinct cytokine profiles in uveitis, an inflammatory eye condition. Higher interleukin 10 levels correlate with visually benign disease, suggesting therapeutic potential.

Area of Science:

  • Ophthalmology
  • Immunology

Background:

  • Uveitis is intraocular inflammation with diverse presentations.
  • Histologically, uveitis involves CD4+ lymphocyte infiltration, regardless of severity.
  • The underlying reasons for varying uveitis severity remain unclear.

Purpose of the Study:

  • To investigate differences in cytokine profiles among various uveitis types.
  • To identify potential biomarkers differentiating benign from blinding uveitis.

Main Methods:

  • Analysis of cytokine profiles in ocular fluids from patients with different uveitis types.
  • Comparison of cytokine levels between visually benign and blinding uveitis cases.

Main Results:

  • Distinct cytokine profiles were observed in different types of intraocular inflammation.

Related Experiment Videos

  • Higher levels of interleukin 10 were found in visually benign uveitis compared to blinding forms.

    • Conclusions:

    • Cytokine profiles, specifically interleukin 10 levels, may distinguish between benign and blinding uveitis.
    • These findings suggest potential new therapeutic strategies targeting cytokine pathways in uveitis.